Menu

• Ask a Health Expert about FOETAL ANTICONVULSANT SYNDROME
• Post Your Side Effect related to FOETAL ANTICONVULSANT SYNDROME
• FOETAL ANTICONVULSANT SYNDROME and FDA Warnings
• FOETAL ANTICONVULSANT SYNDROME in Patients Wiki
• Report FOETAL ANTICONVULSANT SYNDROME in Drug Side Effect Survey

FOETAL ANTICONVULSANT SYNDROME side effect

What is FOETAL ANTICONVULSANT SYNDROME ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Tegretol Side Effects Report #5650513-X
Consumer or non-health professional from UNITED KINGDOM reported TEGRETOL problem on Feb 28, 2008. Male patient was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: foetal anticonvulsant syndrome, . TEGRETOL dosage: unknown. Patient recovered.

Valproate Side Effects Report #5537447-6
VALPROATE problem was reported by a Health Professional from FRANCE on Nov 29, 2007. Male patient, weighting 6.75 lb, was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: foetal anticonvulsant syndrome, . VALPROATE dosage: unknown. During the same period patient was treated with CLOBAZAM, LEVETIRACETAM. Patient recovered.

Tegretol Side Effects Report #5418047-5
Consumer or non-health professional from UNITED KINGDOM reported TEGRETOL problem on May 05, 2006. Female patient, child 8 years of age, was diagnosed with epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: foetal anticonvulsant syndrome, . TEGRETOL dosage: unknown. Patient recovered.

Tegretol Side Effects Report #5707280-0
TEGRETOL problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 08, 2008. Male patient was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: foetal anticonvulsant syndrome, heart disease congenital, . TEGRETOL dosage: unknown. During the same period patient was treated with AMITRIPTYLINE. Patient recovered.


Keppra Side Effects Report #5564642-2
Consumer or non-health professional from UNITED KINGDOM reported KEPPRA problem on Nov 26, 2007. Male patient, weighting 6.75 lb, was diagnosed with convulsion and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: foetal anticonvulsant syndrome, . KEPPRA dosage: unknown. During the same period patient was treated with CLOBAZAM, VALPROATE. Patient recovered.

Valproate Side Effects Report #5576474-X
VALPROATE problem was reported by a Health Professional from FRANCE on Dec 19, 2007. Male patient, weighting 6.75 lb, was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: foetal anticonvulsant syndrome, . VALPROATE dosage: unknown. During the same period patient was treated with CLOBAZAM, LEVETIRACETAM. Patient recovered.

Gabapen Side Effects Report #5727919-3
Physician from JAPAN reported GABAPEN problem on Apr 23, 2008. Male patient, weighting 6.61 lb, was diagnosed with epilepsy and was treated with GABAPEN. After drug was administered, patient experienced the following problems/side effects: foetal anticonvulsant syndrome, gamma-glutamyltransferase increased, hypercalcaemia, . GABAPEN dosage: unknown. During the same period patient was treated with ALEVIATIN, HYDANTOL, CLOBAZAM, FOLIAMIN. Patient was hospitalized. Patient recovered.

Gabapen Side Effects Report #5696251-9
GABAPEN problem was reported by a Physician from JAPAN on Mar 28, 2008. Male patient, weighting 6.61 lb, was treated with GABAPEN. After drug was administered, patient experienced the following problems/side effects: foetal anticonvulsant syndrome, gamma-glutamyltransferase increased, hypercalcaemia, . GABAPEN dosage: unknown. During the same period patient was treated with ALEVIATIN, HYDANTOL, CLOBAZAM. Patient was hospitalized. Patient recovered.

Depakote Side Effects Report #5755620-9
Health Professional from UNITED STATES reported DEPAKOTE problem on May 30, 2008. Male patient, weighting 22.00 lb, was diagnosed with epilepsy and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: developmental delay, dysmorphism, foetal anticonvulsant syndrome, speech disorder, . DEPAKOTE dosage: 500MG BID PO. Patient recovered.